Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Fucidin H 20mg/g + 10mg/g Cream - PA0046/005/005
- Fungizone 50 mg Powder for sterile concentrate - PA2239/004/001
- Targocid 400mg Powder and Solvent for Solution for Injection/infusion or oral solution - PA0540/021/002
- Toviaz 4 mg prolonged-release tablets - EU/1/07/386/003
- Toviaz 8mg prolonged-release tablets - EU/1/07/386/008
- Zoledronic acid 4 mg/5 ml concentrate for solution for infusion - PA2059/019/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Aldactone 25mg Film Coated Tablets - PA0822/110/001
- Desferal 500mg Vials Powder for Solution for Injection or Powder for Concentrate for Solution for Infusion - PA0896/008/001
- Doxatan 2mg tablets - PA0126/202/002
- Efient 5mg tablets - EU/1/08/503/Questran 4g Powder for Oral Suspension - PA2239/005/001
- Losartan Potassium 25mg Film Coated Tablets - PA2315/059/001
- Neoclarityn 0.5mg/ml Oral Solution (100ml) - EU/1/00/161/062
- Solu-Medrone Powder and Solvent for Solution for Injection or Concentrate for Solution for Infusion 125 mg/vial - PA0822/136/002
- Truxima 500mg Concentrate for solution for infusion - EU/1/16/1167/001
- Zithromax capsules 250 mg (6 pack) - PA0822/191/001
Please see the shortages section of the HPRA website for further information.
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.